Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1247876.RAjCm8wV8rgpUSNW-O5VbSHqTWG1fLnRw8p42f7gGBaCA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1247876.RAjCm8wV8rgpUSNW-O5VbSHqTWG1fLnRw8p42f7gGBaCA130_assertion type Assertion NP1247876.RAjCm8wV8rgpUSNW-O5VbSHqTWG1fLnRw8p42f7gGBaCA130_head.
- NP1247876.RAjCm8wV8rgpUSNW-O5VbSHqTWG1fLnRw8p42f7gGBaCA130_assertion description "[In 66.6% of BRCA1 or BRCA2 mutation carriers and in 58.3% of LS mutation carriers, >5 years passed between the cancer diagnoses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1247876.RAjCm8wV8rgpUSNW-O5VbSHqTWG1fLnRw8p42f7gGBaCA130_provenance.
- NP1247876.RAjCm8wV8rgpUSNW-O5VbSHqTWG1fLnRw8p42f7gGBaCA130_assertion evidence source_evidence_literature NP1247876.RAjCm8wV8rgpUSNW-O5VbSHqTWG1fLnRw8p42f7gGBaCA130_provenance.
- NP1247876.RAjCm8wV8rgpUSNW-O5VbSHqTWG1fLnRw8p42f7gGBaCA130_assertion SIO_000772 25503195 NP1247876.RAjCm8wV8rgpUSNW-O5VbSHqTWG1fLnRw8p42f7gGBaCA130_provenance.
- NP1247876.RAjCm8wV8rgpUSNW-O5VbSHqTWG1fLnRw8p42f7gGBaCA130_assertion wasDerivedFrom befree-2016 NP1247876.RAjCm8wV8rgpUSNW-O5VbSHqTWG1fLnRw8p42f7gGBaCA130_provenance.
- NP1247876.RAjCm8wV8rgpUSNW-O5VbSHqTWG1fLnRw8p42f7gGBaCA130_assertion wasGeneratedBy ECO_0000203 NP1247876.RAjCm8wV8rgpUSNW-O5VbSHqTWG1fLnRw8p42f7gGBaCA130_provenance.